Physician profile
Brian Davanzo
NPI 1578974028
$15,144.88
in general payments reported to CMS, 2019-2025
19 companies · $359 in 2025
The $359 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $3,050 · 2021: $296 · 2022: $263 · 2023: $371 · 2024: $716 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,018 · Travel and Lodging: $428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,017.71 |
| Travel and Lodging | $428.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,578.91 | 2019-2024 | Da Vinci Surgical System |
| Tela Bio, INC. | $267.60 | 2021-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Dilon Technologies, INC. | $217.74 | 2025 | Hemoblast Bellows |
| Davol INC. | $200.99 | 2019-2024 | Phasix Mesh |
| Takeda Pharmaceuticals U.S.A., INC. | $178.29 | 2022-2024 | Gattex |
| Organogenesis INC. | $163.44 | 2021-2022 | |
| Medical Device Business Services, INC. | $121.67 | 2019 | |
| Medtronic, INC. | $60.70 | 2022 | |
| Boston Scientific Corporation | $57.94 | 2025 | General - Endochoice |
| Kerecis Limited | $56.60 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $55.93 | 2024-2025 | Renasys Go V2 Home, Renasys Touch |
| Kci USA, INC. | $27.00 | 2020-2021 | |
| Baxter Healthcare | $25.87 | 2025 | Perclot |
| Convatec INC. | $25.63 | 2022 | |
| Distalmotion US | $25.48 | 2025 | Dexter L6 Robot |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $24.30 | 2023 | Peg |
| Stryker Corporation | $23.04 | 2022 | |
| Baudax Bio INC. | $19.03 | 2022 | |
| Conmed Corporation | $14.72 | 2024 | Airseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Davanzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.